Protocol - Awareness of Pharmacogenomics
- Baseline Knowledge of Genomics
- Family Health History
- Medication Inventory
- Medications (Current and Past Use of Pain Relievers, Statins, and Steroids)
Description
This series of questions can be used to determine an individual’s knowledge of pharmacogenomics (PGx) and if the individual is willing to participate in PGx research. It is beneficial for patients to understand that genetic traits may influence the effects of medications and that clinicians are using PGx for patient safety purposes.
Specific Instructions
None
Availability
Protocol
This questionnaire has three sections containing questions about: A) your experiences with diseases and medication use, B) your knowledge on pharmacogenetics, C) your attitude towards pharmacogenetics.
The participation in this survey is voluntary. If you do not want to answer a particular question, you are of course free to do so. Please write the answers to open questions in the space provided. If you need more space, please use the back of the paper and indicate the question number. For all other questions, please use the checkboxes. If you want to change your answer, please put a line through the checked answer and then choose the appropriate box. Always check only one answer except if stated otherwise.
Experiences
Below are some questions about your personal experiences with diseases and medication use.
1. Have you ever experienced a side effect of a medication?
[ ] Yes
[ ] No
[ ] No, but a family member has
[ ] I do not know
2. Have you ever stopped taking a medication because of the side effects of this medication?
[ ] Yes
[ ] No
[ ] I do not know
3. Have you ever stopped taking a medication because you felt that it did not work?
[ ] Yes
[ ] No
[ ] I do not know
4. Do you think that there could be differences between people in their body’s response to medication due to differences in their DNA?
[ ] Yes
[ ] No
[ ] I do not know
Knowledge
These questions enable us to know about your understanding of pharmacogenetics. If you do not know or are not sure, you can also indicate this as the answer.
The DNA stores your hereditary characteristics.
5. Do you think that determining the differences in DNA that are associated with the effect of medication will help to reduce (future) side effects?
[ ] Yes
[ ] No
[ ] I do not know
6. Do you think that knowing the differences in DNA that are associated with the effect of medication will help improve (future) drug treatment?
[ ] Yes
[ ] No
[ ] I do not know
“Pharmacogenetics looks at the influence of your genetic traits on the effect of medication. It is possible that different people break down medication differently due to variations in their genetic traits.”
7. Before you received this questionnaire, have you ever heard of the term “pharmacogenetics”?
[ ] Yes
[ ] No
8.Before you received this questionnaire, did you know the meaning of “pharmacogenetics”?
[ ] Yes
[ ] No
9. Have you ever had a pharmocogenetic test? In a pharmacogenetic test, your hereditary traits related to effect of a medication will be examined.
[ ] Yes
[ ] No
[ ] No, but I have had another kind of DNA test
[ ] I do not know
10. Do you know someone who has had a pharmacogenetic test?
[ ] Yes
[ ] No
[ ] No, but I know someone who has had another type of DNA-test
Attitude
Below are several questions about your views and attitude towards pharmacogenetics.
11. Suppose that your DNA is associated with the effects of your medication. Would you allow your doctor to use the information about your DNA in your future treatment?
[ ] Yes
[ ] No
[ ] I don’t know, I have never thought about this
[ ] I have been thinking about this, but do not know yet
12. Are you willing to have a DNA test before a certain medication is prescribed?
[ ] Yes
[ ] No
[ ] I do not know
13. Do you want your pharmacogenetic information to be used in your treatment with medicines?
[ ] Yes, during the whole treatment
[ ] Yes, but only during my (potential) pregnancy
[ ] No
[ ] No opinion, I don’t know
14. Would you take part in future research related to pharmacogenetics?
[ ] Yes, go to question 16
[ ] No, go to question 15
[ ] I do not know, go to question 15
15. If not, or in doubt, what is the reason (multiple answers are correct)?
[ ] I do not allow my DNA/genetic information to be used in research
[ ] I do not understand the benefit of genetic testing
[ ] I am worried about the consequences
[ ] I am not interested in pharmacogenetic research
[ ] Otherwise, please describe: ____________________________________
16. Would you like to learn more about DNA tests for pharmacogenetics?
[ ] Yes
[ ] No
[ ] I don’t know
17. Which method of getting information about DNA tests for pharmacogenetics do you prefer (multiple answers are correct)?
[ ] Internet
[ ] Information leaflet
[ ] Advice from your pharmacist
[ ] Advice from your GP
[ ] Otherwise, please describe: _______________________________________
Personnel and Training Required
None
Equipment Needs
None
Requirements
Requirement Category | Required |
---|---|
Major equipment | No |
Specialized training | No |
Specialized requirements for biospecimen collection | No |
Average time of greater than 15 minutes in an unaffected individual | No |
Mode of Administration
Self-administered questionnaire
Lifestage
Adult, Pregnancy
Participants
Adults, age 18 and older, and pregnant women
Selection Rationale
This is a questionnaire that has been published in the peer-reviewed literature and is brief and easy to use.
Language
English, Other languages available at source
Standards
Standard | Name | ID | Source |
---|
Derived Variables
None
Process and Review
Not applicable
Protocol Name from Source
Daud, A. N. A., et al. (2017). Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research. BMC Pregnancy Childbirth, 17(1), 120.
Source
Daud, A. N. A., Bergsma, E. L., Bergman, J. E. H., De Walle, H. E. K., Kerstjens-Frederikse, W. S., Bijker, B. J., . . . Wilffert, B. (2017). Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research. BMC Pregnancy Childbirth, 17(1), 120.
Items 8–17, 20-21 and 23–27 from the questionnaire. Questions related to pregnancy are excluded.
General References
Vermeulen, E., Henneman, L., van El, C. G., & Cornel, M. C. (2014). Public attitudes towards preventive genomics and personal interest in genetic testing to prevent disease: a survey study. European Journal of Public Health, 24(5), 768–775.
Protocol ID
310301
Variables
Export VariablesVariable Name | Variable ID | Variable Description | dbGaP Mapping | |
---|---|---|---|---|
PX310301_Awareness_Pharmacogenomics_Differences_Body_Response_Medication | ||||
PX310301040000 | Do you think that there could be differences more | N/A | ||
PX310301_Awareness_Pharmacogenomics_DNA_Information_Future_Treatment | ||||
PX310301110000 | Suppose that your DNA is associated with the more | N/A | ||
PX310301_Awareness_Pharmacogenomics_DNA_Knowledge_Improve_Treatment | ||||
PX310301060000 | Do you think that knowing the differences in more | N/A | ||
PX310301_Awareness_Pharmacogenomics_DNA_Knowledge_Reduce_Side_Effects | ||||
PX310301050000 | Do you think that determining the more | N/A | ||
PX310301_Awareness_Pharmacogenomics_DNA_Test_Before_Prescription | ||||
PX310301120000 | Are you willing to have a DNA test before a more | N/A | ||
PX310301_Awareness_Pharmacogenomics_DNA_Test_Information_Source | ||||
PX310301170100 | Which method of getting information about more | N/A | ||
PX310301_Awareness_Pharmacogenomics_DNA_Test_Information_Source_Other | ||||
PX310301170200 | Which method of getting information about more | N/A | ||
PX310301_Awareness_Pharmacogenomics_DNA_Test_Knowledge | ||||
PX310301160000 | Would you like to learn more about DNA tests more | N/A | ||
PX310301_Awareness_Pharmacogenomics_Heard | ||||
PX310301070000 | Before you received this questionnaire, have more | N/A | ||
PX310301_Awareness_Pharmacogenomics_Meaning | ||||
PX310301080000 | Before you received this questionnaire, did more | N/A | ||
PX310301_Awareness_Pharmacogenomics_Medication_Stopped_Did_Not_Work | ||||
PX310301030000 | Have you ever stopped taking a medication more | N/A | ||
PX310301_Awareness_Pharmacogenomics_Partake_Future_Research | ||||
PX310301140000 | Would you take part in future research more | N/A | ||
PX310301_Awareness_Pharmacogenomics_Partake_Future_Research_Reason_Decline | ||||
PX310301150100 | If not, or in doubt, what is the reason more | N/A | ||
PX310301_Awareness_Pharmacogenomics_Partake_Future_Research_Reason_Decline_Other | ||||
PX310301150200 | If not, or in doubt, what is the reason more | N/A | ||
PX310301_Awareness_Pharmacogenomics_Pharmacogenomic_Information_Use_Treatment | ||||
PX310301130000 | Do you want your pharmacogenetic information more | N/A | ||
PX310301_Awareness_Pharmacogenomics_Side_Effect_Medication_Experience | ||||
PX310301010000 | Have you ever experienced a side effect of a more | N/A | ||
PX310301_Awareness_Pharmacogenomics_Side_Effect_Medication_Stopped | ||||
PX310301020000 | Have you ever stopped taking a medication more | N/A | ||
PX310301_Awareness_Pharmacogenomics_Test | ||||
PX310301090000 | Have you ever had a pharmacogenetic test? In more | N/A | ||
PX310301_Awareness_Pharmacogenomics_Test_Other_Person | ||||
PX310301100000 | Do you know someone who has had a more | N/A |
Measure Name
Awareness of Pharmacogenomics
Release Date
September 10, 2020
Definition
A questionnaire used to determine general knowledge about pharmacogenomics and how an individual’s genes can influence drug effectiveness.
Purpose
Pharmacogenomics (PGx) is the role of the genome in drug response and is a tool available to healthcare providers, especially those engaged in precision medicine. Genes influence drug response, and it is important that patients have a basic understanding of genes and PGx.
Keywords
genetic counseling, genetic testing, genomic testing, medication, pharmacogenomics, PGx
Measure Protocols
Protocol ID | Protocol Name |
---|---|
310301 | Awareness of Pharmacogenomics |
Publications
There are no publications listed for this protocol.